Friday, 16 September 2011

7 important heart health screenings

Cardiovascular disease (CVD) is a serious health issue affecting a developing nation like India. In the coming years, the projected increase in disease burden due to CVD will make it a prime cause of mortality in India.

High obesity rates, low physical activity and unhealthy lifestyles, work together to increase the incidence of the condition. Further, more than half cardiac death cases occur in persons without any previous history of heart disease. This makes frequent heart health screenings vital to your health. The top 7 health screenings are as follows.

Blood pressure monitoring

Classified by WHO as a leading cause of cardiovascular mortality, it is possible to detect this 'silent killer' by merely checking your blood-pressure levels with the help of a sphygmomanometer and a stethoscope. Hypertension is commonly associated with heart ailments like stroke, heart attack and heart failure. Hence, frequent screening is vital especially if you have adverse lifestyle habits or a family history of high blood pressure. The standard blood pressure readings for adults are 90-119 mmHg Systolic and 60-79 mmHg Diastolic. Any variations from this level calls for regular checkups and lifestyle changes.

Body weight measurements

The BMI (Body Mass Index) is a simple test that helps doctors diagnose cardiovascular conditions. Apart from this, measurement of the waist circumference is also important. These measurements tell us if we are at the desired weight for our age. With increasing cases of obesity, people today are at a higher risk of increased blood pressure, cholesterol and triglycerides. Development of these risk factors, in turn, triggers heart ailments. As per WHO standards, a BMI of 18.5 to 25 kg per meter square is regarded as normal and values greater than 25 overweight and above 30 is considered as obese.

Blood glucose level

An important biomarker offering detailed information about the risk of developing CVD is the blood glucose level. It is mandatory to check your blood glucose levels every three years after reaching the age of 45. Increased levels place you at a higher risk of Type II Diabetes which, in turn, can trigger a heart disease or stroke. In case, you have two or more cardiovascular risk factors at the same time, it is advisable to get this screening test done even before the age of 45.

Fasting lipoproteins

The American Heart Association recommends that a woman above 50 years of age and a man above 45 should test their fasting lipoprotein profile every five years. Another high risk group includes people with two or more risk factors at the same time. This test includes measurement of total cholesterol, LDL cholesterol (bad), HDL cholesterol (good) and triglycerides.

Stress test

Stress testing is a vital mode for diagnosing coronary heart disease (CHD), also called coronary artery disease. This provides important data about how your heart functions during strenuous physical activity. Signs of CHD are difficult to assess while at rest. But while performing exercises, the increased oxygen supply required by the working heart is not met due to the narrowed arteries in CHD patients. The main parameters measured during stress test are abnormal heart rate and blood pressure levels, shortness of breath, chest pain and abnormal changes in your heart rhythm.

Artery ultrasound

In heart patients, images obtained by ultrasound testing help physicians to diagnose any blocks or plagues in the carotid arteries of the neck or hazardous bulges in the abdominal aortic artery. It also helps to diagnose certain hidden heart ailments in patients having no prior symptoms. As per researches, periodic ultrasound screening in men aged 60-70 years can be reduced to more than 50 percent.

Electrocardiography

A high-tech screening module using for diagnosing heart ailments is Electrocardiography (ECG or EKG). Routine screening with the help of this non-invasive test helps to detect certain CVDs like coronary heart disease and coronary artery stenosis.

Monday, 5 September 2011

WHO joins with FIP for combating TB

The World Health Organisation and the International Pharmaceutical Federation (FIP) signed a joint statement here on Sunday seeking to involve pharmacists in tuberculosis care and control. It's a major initiative to combat TB epidemic. The statement was signed by Hiroki Nakatani, WHO Assistant Director-General for HIV/AIDS, TB, Malaria and Neglected Tropical Diseases and FIP president, Michel Buchmann, at the World Congress of Pharmacy and Pharmaceutical Sciences 2011 and the 71st International Congress of FIP. The event was organized by President Pratibha Patil earlier. 

Dr. Nakatani said that TB was one of the major killers worldwide claiming five million lives per year. Referring to the emergence of multi-drug resistant TB due to underuse, overuse and misuse of anti-TB drugs, he insisted out that India was home to largest burden of TB patients and emphasised the necessity of collaboration with pharmacists. FIP president Michel Buchmann revealed that FIP would endeavour to support WHO and its member States in enabling national TB programmes and national pharmacy associations to enhance their collaboration towards care and control of TB and multi-drug resistant TB globally. 

The statement called upon TB programmes and pharmacy associations to engage pharmacists in the fight against TB by increasing awareness of TB, referring people with TB symptoms to facilities with quality diagnosis and treatment, offering patient-centric treatment supervision to improve adherence and help prevent multi-drug resistant TB and promoting the rational use of anti-TB medicines. Meanwhile, FIP honoured several individuals for their outstanding dedication to the development of pharmacy and science . The awards include FIP Distinguished Practice Award to Dr.Marianne F. Ivey (USA) and FIP Lifetime Achievment in Pharmaceutical Practice Award to Dr. Th ( Dick) Tromp (The Netherlands).